ClinicalTrials.Veeva

Menu

Vitamin D Treatment to Patients Suffering From Chronic Pain and Vitamin D Hypovitaminosis

T

Tel Aviv Sourasky Medical Center

Status

Completed

Conditions

Back Pain
Hypovitaminosis D

Treatments

Drug: Placebo
Drug: Vitamin D

Study type

Interventional

Funder types

Other

Identifiers

NCT01023490
TASMC-09-SB-0494-CTIL

Details and patient eligibility

About

The objective of this study is to check whether vitamin D will lead to a decrease in pain intensity compare to placebo, in patients suffering from chronic pain.

Full description

Vitamin D is a complex nutrient that functions as a hormone to benefit numerous body tissues.

Vitamin D is naturally produced by skin exposed to ultraviolet B. Despite the fact that Israel is a sunny country, a majority of all patients, and particularly those with pain, have inadequate intake of vitamin D.

Vitamin D therapy is easy for patients to self administer, well tolerated, and very economical.

In this study, we'll check whether vitamin D will lead to a decrease in pain intensity in patients suffering from chronic low back pain.

Enrollment

12 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • men and women over 18, who suffer from chronic pain and hypovitaminosis D

Exclusion criteria

  • patients that are treated with vitamin D

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

12 participants in 2 patient groups, including a placebo group

Placebo
Placebo Comparator group
Treatment:
Drug: Placebo
Vitamin D
Active Comparator group
Description:
34,500 IU vitamin D per week
Treatment:
Drug: Vitamin D

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems